BiotechTube
Home/Pipeline/Traumatic Brain Injury (TBI) Implant

Traumatic Brain Injury (TBI) Implant

Traumatic Brain Injury

PreclinicalActive

Key Facts

Indication
Traumatic Brain Injury
Phase
Preclinical
Status
Active
Company
Matricelf

About Matricelf

Autologous iPSC‑based tissue implants for curative spinal cord injury and broader regenerative medicine.

View full company profile

Therapeutic Areas

Spinal Cord InjuryTraumatic Brain InjuryStrokeMyocardial Infarction

Other Traumatic Brain Injury Drugs

DrugCompanyPhase
Presendin™ (Exenatide)Invex TherapeuticsPreclinical
TBI Modeling PlatformbmseedResearch Tool
TV-301TheraVac BiologicsPreclinical
TBI IndicationHera Health SolutionsProof of Concept/Bench Validation
NA-731BiomedPhase 2A
Fv-Hsp72 for TBIRubicon BiotechnologyPre-clinical
TBI Treatment SystemVivonicsDevelopment/Testing